Please provide your email address to receive an email when new articles are posted on . TMB-001 is an investigational topical reformulation of isotretinoin for the treatment of congenital ichthyosis.

Please provide your email address to receive an email when new articles are posted on . A new topical isotretinoin formula was safe and efficacious in the treatment of congenital ichthyosis, according ...

(MENAFN- Investor Ideas) Patient recruitment is 50% complete for this multicenter study evaluating a designated orphan drug as treatment for these congenital disorders, noted an H.C. Wainwright & Co.

BASKING RIDGE, NJ, Sept. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company ...

Harlequin ichthyosis, also called ichthyosis congenital, is a genetic disorder that mainly affects the skin of newborn babies. Babies with this condition develop a thick, dry and scaly skin consisting ...

BASKING RIDGE, NJ, May 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company ...

BRANFORD, Conn. - Azitra, Inc. (NYSE American:AZTR), a clinical-stage biotech company currently trading near its 52-week low of $0.68, announced positive preclinical results for its ATR-01 program ...

On Thursday evening, Bilai Aden sat on her hotel bed, rocking her 10 month old baby. The baby’s face was covered in a black hood and blanket, but Bilai would occasionally lift the fabric and peer ...